Skip to main content

Advertisement

Log in

Computed tomography nomogram to predict a high-risk intraductal papillary mucinous neoplasm of the pancreas

  • Pancreas
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Objective

The intraductal papillary mucinous neoplasm (IPMN) of the pancreas is regarded as a precursor to pancreatic cancer; this study aimed to develop and validate a model based on CT characteristics for the non-invasive prediction of the high-risk IPMN of the pancreas.

Materials and methods

In this retrospective study, all patients underwent multidetector CT and surgical resection. A prediction model was developed based on a training set consisting of 136 patients with low-risk IPMN and 85 patients with high-risk IPMN between October 2012 and April 2019, and a multivariable logistic regression model was adopted to establish a nomogram. The nomogram performance was determined by its discrimination, calibration, and clinical usefulness. The model was validated in 80 consecutive patients between May 2019 and April 2020, of which 47 and 33 patients had low-risk and high-risk IPMNs, respectively.

Results

The multivariable logistic regression model of CT characteristics included the enhancing mural nodule size, the main pancreatic duct (MPD) diameter, the abrupt change in caliber of the MPD with distal pancreatic atrophy, cyst size, thickened enhancing cyst wall, and the presence of lymphadenopathy. The individualized prediction nomogram using these predictors of the high-risk IPMN achieved an area under the curve (AUC) of 0.92 (95% CI 0.88–0.95) in the training set and 0.87 (95% CI 0.79–0.95) in the validation set. The decision curve analysis demonstrated that the nomogram was clinically useful.

Conclusion

The CT nomogram, which is a non-invasive predictive tool, can preoperatively predict the risk of malignant IPMN and help identify patients who require a surgical procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. van Huijgevoort NCM, Del Chiaro M, Wolfgang CL, et al. (2019) Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines. Nat Rev Gastroenterol Hepatol 16 (11):676–89. https://doi.org/10.1038/s41575-019-0195-x

  2. European Study Group on Cystic Tumours of the P. (2018) European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67 (5):789–804. https://doi.org/10.1136/gutjnl-2018-316027

  3. Choi SH, Park SH, Kim KW, et al. (2017) Progression of Unresected Intraductal Papillary Mucinous Neoplasms of the Pancreas to Cancer: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 15 (10):1509–20 e4. https://doi.org/10.1016/j.cgh.2017.03.020

  4. Tanaka M, Fernandez-del Castillo C, Adsay V, et al. (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12 (3):183–97. https://doi.org/10.1016/j.pan.2012.04.004

  5. Sugimoto M, Elliott IA, Nguyen AH, et al. (2017) Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct. JAMA Surg 152 (1):e163349. https://doi.org/10.1001/jamasurg.2016.3349

  6. Tanaka M, Fernandez-Del Castillo C, Kamisawa T, et al. (2017) Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 17 (5):738–53. https://doi.org/10.1016/j.pan.2017.07.007

  7. Shimizu Y, Kanemitsu Y, Sano T, et al. (2010) A nomogram for predicting the probability of carcinoma in patients with intraductal papillary-mucinous neoplasm. World J Surg 34 (12):2932–8. https://doi.org/10.1007/s00268-010-0785-9

  8. Correa-Gallego C, Do R, Lafemina J, et al. (2013) Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol 20 (13):4348–55. https://doi.org/10.1245/s10434-013-3207-z

  9. Shimizu Y, Yamaue H, Maguchi H, et al. (2015) Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers. Pancreas 44 (3):459–64. https://doi.org/10.1097/MPA.0000000000000269

  10. Goh BK, Teo JY, Allen JC, Jr., et al. (2016) Preoperative platelet-to-lymphocyte ratio improves the performance of the international consensus guidelines in predicting malignant pancreatic cystic neoplasms. Pancreatology 16 (5):888–92. https://doi.org/10.1016/j.pan.2016.06.660

  11. Jang JY, Park T, Lee S, et al. (2017) Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg 266 (6):1062–8. https://doi.org/10.1097/SLA.0000000000001985

  12. Attiyeh MA, Fernandez-Del Castillo C, Al Efishat M, et al. (2018) Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. Ann Surg 267 (1):157–63. https://doi.org/10.1097/SLA.0000000000002015

  13. Shimizu Y, Hijioka S, Hirono S, et al. (2020) New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm. Ann Surg 272 (1):155–62. https://doi.org/10.1097/SLA.0000000000003108

  14. Moons KG, Altman DG, Reitsma JB, et al. (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162 (1):W1–73. https://doi.org/10.7326/M14-0698

  15. Lee JE, Choi SY, Min JH, et al. (2019) Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines. Radiology 293 (1):134–43. https://doi.org/10.1148/radiol.2019190144

  16. Chiu SS, Lim JH, Lee WJ, et al. (2006) Intraductal papillary mucinous tumour of the pancreas: differentiation of malignancy and benignancy by CT. Clin Radiol 61 (9):776–83. https://doi.org/10.1016/j.crad.2006.04.008

  17. Kang HJ, Lee JM, Joo I, et al. (2016) Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography. Radiology 279 (1):128–39. https://doi.org/10.1148/radiol.2015150217

  18. Dorfman RE, Alpern MB, Gross BH, et al. (1991) Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 180 (2):319–22. https://doi.org/10.1148/radiology.180.2.2068292

  19. Nagtegaal ID, Odze RD, Klimstra D, et al. (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76 (2):182-8. https://doi.org/10.1111/his.13975

  20. Shrout PE, Fleiss JL. (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86 (2):420–8. https://doi.org/10.1037//0033-2909.86.2.420

  21. Howard TJ, Chin AC, Streib EW, et al. (1997) Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma. Am J Surg 174 (3):237–41.

  22. Imai H, Doi R, Kanazawa H, et al. (2010) Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer. Int J Clin Oncol 15 (3):294–300. https://doi.org/10.1007/s10147-010-0066-5

  23. Midwinter MJ, Beveridge CJ, Wilsdon JB, et al. (1999) Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 86 (2):189–93. https://doi.org/10.1046/j.1365-2168.1999.01042.x

  24. Nanashima A, Tobinaga S, Abo T, et al. (2012) Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute. Hepatogastroenterology 59 (115):911–5. https://doi.org/10.5754/hge10038

  25. Igarashi T, Ashida H, Morikawa K, et al. (2018) Evaluating the malignant potential of intraductal papillary mucinous neoplasms of the pancreas: added value of non-enhanced endoscopic ultrasound to supplement non-enhanced magnetic resonance imaging. Pol J Radiol 83:e426-e36. https://doi.org/10.5114/pjr.2018.79617

  26. Kwong WT, Lawson RD, Hunt G, et al. (2015) Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy. Dig Dis Sci 60 (9):2800–6. https://doi.org/10.1007/s10620-015-3679-8

  27. Kang HJ, Lee DH, Lee JM, et al. (2020) Clinical Feasibility of Abbreviated Magnetic Resonance With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm. Invest Radiol 55 (5):262–9. https://doi.org/10.1097/RLI.0000000000000636

Download references

Funding

This work was supported in part by the National Natural Science Foundation of China (81871352); Major Clinical Research Project of Shanghai Shenkang Hospital Development Center (SHDC2020CR4073); The Natural Science Foundation of Shanghai Science and Technology Innovation Action Plan (21ZR1478500); 234 Platform Discipline Consolidation Foundation Project (2019YPT001).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Chengwei Shao or Yun Bian.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fang, X., Liu, F., Li, J. et al. Computed tomography nomogram to predict a high-risk intraductal papillary mucinous neoplasm of the pancreas. Abdom Radiol 46, 5218–5228 (2021). https://doi.org/10.1007/s00261-021-03247-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-021-03247-w

Keywords

Navigation